Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation
出版年份 2017 全文链接
标题
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation
作者
关键词
-
出版物
Oncogenesis
Volume 6, Issue 5, Pages e337
出版商
Springer Nature
发表日期
2017-05-15
DOI
10.1038/oncsis.2017.36
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia
- (2016) G. Olombel et al. BLOOD
- Clinical detection and categorization of uncommon and concomitant mutations involving BRAF
- (2015) Gang Zheng et al. BMC CANCER
- Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma
- (2015) Brian A. Walker et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibiting MEK in MAPK pathway-activated myeloma
- (2015) C J Heuck et al. LEUKEMIA
- Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy
- (2015) R Mandal et al. ONCOGENE
- Semiconductor-Based Sequencing of Formalin-Fixed, Paraffin-Embedded Colorectal Cancer Samples
- (2015) A. Stenzinger et al. ONCOLOGIST
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
- (2014) Jens G. Lohr et al. CANCER CELL
- Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
- (2014) Niccolo Bolli et al. Nature Communications
- Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy
- (2013) G. Mulligan et al. BLOOD
- Molecular Diagnostic Profiling of Lung Cancer Specimens with a Semiconductor-Based Massive Parallel Sequencing Approach
- (2013) Volker Endris et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Targeting the BRAF V600E Mutation in Multiple Myeloma
- (2013) M. Andrulis et al. Cancer Discovery
- Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma
- (2012) B. A. Walker et al. BLOOD
- A Comprehensive Survey of Ras Mutations in Cancer
- (2012) I. A. Prior et al. CANCER RESEARCH
- RAF around the Edges — The Paradox of BRAF Inhibitors
- (2012) Ashani T. Weeraratna NEW ENGLAND JOURNAL OF MEDICINE
- Progression of RAS-Mutant Leukemia during RAF Inhibitor Treatment
- (2012) Margaret K. Callahan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Initial genome sequencing and analysis of multiple myeloma
- (2011) Michael A. Chapman et al. NATURE
- BRAFMutations in Hairy-Cell Leukemia
- (2011) Enrico Tiacci et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRAF Inactivation Drives Aneuploidy by Deregulating CRAF
- (2010) T. Kamata et al. CANCER RESEARCH
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma
- (2008) A. Zollinger et al. BLOOD
- SnapShot: Ras Signaling
- (2008) Megan Cully et al. CELL
- CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations
- (2008) K S M Smalley et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started